← All stocks

Krystal Biotech, Inc.

KRYS Net selling

CIK 0001711279 #938 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$105.27M

$74.52M on a plan · $22.53M straight out of an exercise

Sold at will

$8.23M

8 of 142 sales

Net

−$105.27M

−$8.23M against sales at will

By person

6 insiders · 142 transactions

1,296×

Krish S. Krishnan holds 1,296 times base salary in stock. $1.10B of shares against $846.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Krish S. Krishnan last reported holding, valued at $366.56, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Krishnan Suma

President, R&D

—

$34.27M (50) scheduled

−$34.27M

2,993,408

10.11%

$1.10B

−6.5%

Krishnan Krish S

President and CEO

—

$34.27M (50) scheduled

−$34.27M

2,993,408

10.11%

$1.10B

−6.5%

JANNEY DANIEL

Director

—

$19.40M (22) scheduled

−$19.40M

73,293

0.2476%

$26.87M

−31.7%

ROSSI DINO A

Director

—

$13.18M (10)

−$13.18M

50,000

0.1689%

$18.33M

−36.5%

ROMANO KATHRYN

Chief Accounting Officer

—

$3.60M (8) scheduled

−$3.60M

22,366

0.0756%

$8.20M

+43.2%

Thomas John Charles

EVP, General Counsel

—

$541.17K (2) scheduled

−$541.17K

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 107

Sales straight out of an exercise 27

Sales at will 8

Transactions with no price 0

Shares from compensation/vesting 291,956

History held since 25 Sep 2017